Clinical Trial Update: Efficacy and Safety of Cyclobenzaprine Hydrochloride Extended Release for the Treatment of Chronic Migraine [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating cyclobenzaprine hydrochloride extended-release for chronic migraine was terminated; the update notes the study status without detaili…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Cyclobenzaprine Hydrochloride Extended Release (cyclobenzaprine hydrochloride extended release)

Snippet

Sponsor: Kennedy Medical Group | Conditions: Chronic Migraine | Phase 3 | Status: TERMINATED